Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: NOVAVAX INC, NOVAVAX, INC, NOVAVAX, INC., Novavax, Inc., NOVAVAX, INC, NOVAVAX, INC.
Client-Reported Lobbying Expenses
$3.5M
132 filings
Firm Income Reported for This Client
$2.5M
Not substituted for client expenses
SEC Insider
$372.5M
2,213 transactions
Summary
NOVAVAX, INC. (NVAX) is an organization, based in MD. Its political footprint includes $3.5 million in client-reported lobbying expenses, $2.5 million in lobbying-firm income reported for this client. Lobbying activity focuses on Health Issues, Taxation/Internal Revenue Code, Budget/Appropriations, Medical/Disease Research/Clinical Labs. Political activity spans from 2009 to 2026.
These are different money flows and are not added together: contributions and lobbying expenses flow out, while contract awards flow to the organization.
Lobbying Spend Trend
↑ 71% YoY
2025: $700K (complete years)
Insider Trading
48 insiders
SEC filings: SEC EDGAR
Activity data: Senate LDA · SEC EDGAR